Windlas Biotech (NSE:WINDLAS) FFO


NSE:WINDLAS Windlas Biotech Ltd NSE:WINDLAS
86 GF Score
Price ₹859.00
GF Value ₹937.25
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Windlas Biotech FFO?

FFO (Funds from operations) only applies to REITs.

NSE:WINDLAS
86GF Score
Windlas Biotech Ltd NSE:WINDLAS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Windlas Biotech (NSE:WINDLAS) Overvalued in 2026?

Based on GuruFocus' analysis, Windlas Biotech stock appears to be undervalued. The current stock price of ₹859.00 is trading 8.3% below its estimated GF Value™ of ₹937.25. GuruFocus considers Windlas Biotech to be Fairly Valued.

Key valuation signals for NSE:WINDLAS:

  • FFO:
  • GF Value™: ₹937.25 vs. price of ₹859.00 (8.3% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the NSE:WINDLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Windlas Biotech Business Description

Other Exchanges 543329:India
Address Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
86GF Score

Get the complete analysis for NSE:WINDLAS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹859.00
Price
₹937.25
GF Value